Selenium inhibits migration of murine melanoma cells via down-modulation of IL-18 expression

Hyunkeun Song, Jiyoung Kim, Hyun Kyung Lee, Hyun Jin Park, Joohyung Nam, Ga Bin Park, Yeong Seok Kim, Dae Ho Cho, Dae Young Hur

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Melanoma is an aggressive form of skin cancer due to its rapid metastasis. Recently, several studies have reported that selenium can prevent metastasis of melanoma cells, but the mechanism of this anti-metastatic ability is not fully understood. In this study, we investigated the effect of selenium on cell migration in melanoma and on tumor metastasis in mice. Interestingly, tumor metastasis was suppressed by selenium in a mouse model. Cell migration was measured by a wound-healing assay using selenium-treated melanoma cells. Treatment with a non-cytotoxic concentration of selenium suppressed migration of melanoma cells in a dose-dependent manner. In addition, we found decreased HIF-1α and VEGF expression in selenium-treated melanoma cells as compared to non-treated control cells. Mechanistically, our studies show that selenium inhibits IL-18 gene expression in a dose-dependent manner. IL-18 protein level was suppressed by treatment with selenium. The wound-healing assay revealed that the anti-metastatic effect of selenium was abrogated by treatment with exogenous IL-18. These results suggest that selenium might be a potent inhibitor of the metastatic capacity of melanoma cells, via down-modulation of IL-18 expression.

Original languageEnglish
Pages (from-to)2208-2213
Number of pages6
JournalInternational Immunopharmacology
Volume11
Issue number12
DOIs
Publication statusPublished - 2011 Dec 1
Externally publishedYes

Fingerprint

Interleukin-18
Selenium
Melanoma
Neoplasm Metastasis
Cell Movement
Wound Healing
Skin Neoplasms
Vascular Endothelial Growth Factor A
Neoplasms
Gene Expression

Keywords

  • IL-18
  • Migration
  • Selenium
  • Tumor immunity

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology

Cite this

Song, H., Kim, J., Lee, H. K., Park, H. J., Nam, J., Park, G. B., ... Hur, D. Y. (2011). Selenium inhibits migration of murine melanoma cells via down-modulation of IL-18 expression. International Immunopharmacology, 11(12), 2208-2213. https://doi.org/10.1016/j.intimp.2011.10.002

Selenium inhibits migration of murine melanoma cells via down-modulation of IL-18 expression. / Song, Hyunkeun; Kim, Jiyoung; Lee, Hyun Kyung; Park, Hyun Jin; Nam, Joohyung; Park, Ga Bin; Kim, Yeong Seok; Cho, Dae Ho; Hur, Dae Young.

In: International Immunopharmacology, Vol. 11, No. 12, 01.12.2011, p. 2208-2213.

Research output: Contribution to journalArticle

Song, Hyunkeun ; Kim, Jiyoung ; Lee, Hyun Kyung ; Park, Hyun Jin ; Nam, Joohyung ; Park, Ga Bin ; Kim, Yeong Seok ; Cho, Dae Ho ; Hur, Dae Young. / Selenium inhibits migration of murine melanoma cells via down-modulation of IL-18 expression. In: International Immunopharmacology. 2011 ; Vol. 11, No. 12. pp. 2208-2213.
@article{d103323797e546c0a5f9562f8aa70b73,
title = "Selenium inhibits migration of murine melanoma cells via down-modulation of IL-18 expression",
abstract = "Melanoma is an aggressive form of skin cancer due to its rapid metastasis. Recently, several studies have reported that selenium can prevent metastasis of melanoma cells, but the mechanism of this anti-metastatic ability is not fully understood. In this study, we investigated the effect of selenium on cell migration in melanoma and on tumor metastasis in mice. Interestingly, tumor metastasis was suppressed by selenium in a mouse model. Cell migration was measured by a wound-healing assay using selenium-treated melanoma cells. Treatment with a non-cytotoxic concentration of selenium suppressed migration of melanoma cells in a dose-dependent manner. In addition, we found decreased HIF-1α and VEGF expression in selenium-treated melanoma cells as compared to non-treated control cells. Mechanistically, our studies show that selenium inhibits IL-18 gene expression in a dose-dependent manner. IL-18 protein level was suppressed by treatment with selenium. The wound-healing assay revealed that the anti-metastatic effect of selenium was abrogated by treatment with exogenous IL-18. These results suggest that selenium might be a potent inhibitor of the metastatic capacity of melanoma cells, via down-modulation of IL-18 expression.",
keywords = "IL-18, Migration, Selenium, Tumor immunity",
author = "Hyunkeun Song and Jiyoung Kim and Lee, {Hyun Kyung} and Park, {Hyun Jin} and Joohyung Nam and Park, {Ga Bin} and Kim, {Yeong Seok} and Cho, {Dae Ho} and Hur, {Dae Young}",
year = "2011",
month = "12",
day = "1",
doi = "10.1016/j.intimp.2011.10.002",
language = "English",
volume = "11",
pages = "2208--2213",
journal = "International Immunopharmacology",
issn = "1567-5769",
publisher = "Elsevier",
number = "12",

}

TY - JOUR

T1 - Selenium inhibits migration of murine melanoma cells via down-modulation of IL-18 expression

AU - Song, Hyunkeun

AU - Kim, Jiyoung

AU - Lee, Hyun Kyung

AU - Park, Hyun Jin

AU - Nam, Joohyung

AU - Park, Ga Bin

AU - Kim, Yeong Seok

AU - Cho, Dae Ho

AU - Hur, Dae Young

PY - 2011/12/1

Y1 - 2011/12/1

N2 - Melanoma is an aggressive form of skin cancer due to its rapid metastasis. Recently, several studies have reported that selenium can prevent metastasis of melanoma cells, but the mechanism of this anti-metastatic ability is not fully understood. In this study, we investigated the effect of selenium on cell migration in melanoma and on tumor metastasis in mice. Interestingly, tumor metastasis was suppressed by selenium in a mouse model. Cell migration was measured by a wound-healing assay using selenium-treated melanoma cells. Treatment with a non-cytotoxic concentration of selenium suppressed migration of melanoma cells in a dose-dependent manner. In addition, we found decreased HIF-1α and VEGF expression in selenium-treated melanoma cells as compared to non-treated control cells. Mechanistically, our studies show that selenium inhibits IL-18 gene expression in a dose-dependent manner. IL-18 protein level was suppressed by treatment with selenium. The wound-healing assay revealed that the anti-metastatic effect of selenium was abrogated by treatment with exogenous IL-18. These results suggest that selenium might be a potent inhibitor of the metastatic capacity of melanoma cells, via down-modulation of IL-18 expression.

AB - Melanoma is an aggressive form of skin cancer due to its rapid metastasis. Recently, several studies have reported that selenium can prevent metastasis of melanoma cells, but the mechanism of this anti-metastatic ability is not fully understood. In this study, we investigated the effect of selenium on cell migration in melanoma and on tumor metastasis in mice. Interestingly, tumor metastasis was suppressed by selenium in a mouse model. Cell migration was measured by a wound-healing assay using selenium-treated melanoma cells. Treatment with a non-cytotoxic concentration of selenium suppressed migration of melanoma cells in a dose-dependent manner. In addition, we found decreased HIF-1α and VEGF expression in selenium-treated melanoma cells as compared to non-treated control cells. Mechanistically, our studies show that selenium inhibits IL-18 gene expression in a dose-dependent manner. IL-18 protein level was suppressed by treatment with selenium. The wound-healing assay revealed that the anti-metastatic effect of selenium was abrogated by treatment with exogenous IL-18. These results suggest that selenium might be a potent inhibitor of the metastatic capacity of melanoma cells, via down-modulation of IL-18 expression.

KW - IL-18

KW - Migration

KW - Selenium

KW - Tumor immunity

UR - http://www.scopus.com/inward/record.url?scp=81855169987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81855169987&partnerID=8YFLogxK

U2 - 10.1016/j.intimp.2011.10.002

DO - 10.1016/j.intimp.2011.10.002

M3 - Article

C2 - 22008306

AN - SCOPUS:81855169987

VL - 11

SP - 2208

EP - 2213

JO - International Immunopharmacology

JF - International Immunopharmacology

SN - 1567-5769

IS - 12

ER -